arrow
Back
D

Diwakar Davar

university of pittsburgh

31H-index
317Paper Count
5.9KCitation Count
Published Papers 55
Publication Date
Microbiome modulation in cancer immunotherapy
err2026-03-09
err0
PREAI
errSumanta K. Pal; Diwakar Davar
errShare
errSave
Image Biomarkers for Predicting Immunotherapy Response in Advanced Melanoma
err2025-11-01
err0
PREAI
errKokenberger, Grant; Singh, Jatin; Yu, Tong; Meng, Xin; Hurd, Drew; Nguyen, Madison; McKay, William; Kirkwood, John M.; Zarour, Hassane M.; Davar, Diwakar; Pu, Jiantao
errShare
errSave
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations
err2025-11-01
err0
PREAI
errNguyen, Matthew K.; Jelinek, Mark; Singh, Arjun; Isett, Brian; Myers, Erica S.; Mullett, Steven J.; Eisele, Yvonne; Beumer, Jan H.; Parise, Robert A.; Urban, Julie; Rose, Amy; Sellitto, Lorenzo; Singh, Krishna; Doerfler, Rose; Dadey, Rebekah E.; Kim, Carl; Rhee, John C.; Davar, Diwakar; Villaruz, Liza C.; Burgess, Melissa; Drappatz, Jan; Mantica, Megan; Goodman, Amy E.; Wang, Hong; Singhi, Aatur D.; Luke, Jason J.; Zandberg, Dan P.; Bao, Riyue
errShare
errSave
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938)
errCancer
IF5.1
err2025-10-29
err0
PREAI
errLiza C. Villaruz MD; Jingxiao Jin MD; Hong Wang PhD; James J. Lee MD, PhD; Jason J. Luke MD; John C. Rhee MD; Saiama N. Waqar MD; Geoffrey I. Shapiro MD, PhD; James Cleary MD, PhD; Diwakar Davar MD; Timothy F. Burns MD, PhD; Rashmi Verma MD; Manik Amin MD; Leonard Appleman MD, PhD; Kristen K. Ciombor MD; Elizabeth J. Davis MD; Jonathan W. Riess MD; E. Claire Dees MD; Edward J. Kim MD, PhD; Dana Cardin MD; Jianxia Guo PhD; Susan M. Christner BS; Joshua Deppas MS; Angelina M. Parise BS; John C. Schmitz PhD; Bella S. Guerrouahen PhD; Michael Suchko BS; Alejandro Contreras MD, PhD; Li Li PhD; Katherine V. Ferry-Galow PhD; Ting-Chia Chang MS; Shahanawaz Jiwani MD, PhD; Christopher J. Bakkenist PhD; Edward Chu MD; Steven D. Gore MD; Jan H. Beumer PharmD, PhD
errShare
errSave
A phase I study of the OX40 agonist BGB-A445 with or without tislelizumab, an anti–PD-1 monoclonal antibody, in patients with advanced solid tumors: dose-escalation results
err2025-10-08
err0
errOAAI
errJayesh Desai; Sanjeev Deva; Bo Gao; Kunyu Yang; Kenneth J. O’Byrne; Meili Sun; Tianshu Liu; Tarek Meniawy; Xinmin Yu; Mark Voskoboynik; Diwakar Davar; Marco Matos; Shiangjiin Leaw; Tahmina Rahman; Xiaofei Qu; Hugh Giovinazzo; Xin Chen; Yan Dong; Daphne Day
errShare
errSave
Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy
errCell
IF42.5
err2025-07-09
err0
PREAI
errCatherine M. Phelps; Nathaniel B. Willis; Tingting Duan; Amanda H. Lee; Yue Zhang; Daphne M. Rodriguez J; Surya P. Pandey; Colin R. Laughlin; Aaron B.I. Rosen; Alex C. McPherson; Jake H. Shapira; Simran K. Randhawa; Lee Hedden; Tanner G. Richie; Hallie M. Wiechman; Mackenzie J. Bender; Ina Nemet; Patrick A. Zöhrer; Rachel A. Gottschalk; Kathryn H. Schmitz; Steven J. Mullett; Stacy L. Gelhaus; Diwakar Davar; Hassane M. Zarour; Reinhard Hinterleitner; Thomas Mossington; Jonathan H. Badger; Richard R. Rodrigues; John A. McCulloch; Sonny T.M. Lee; Karl-Heinz Wagner; Maria G. Winter; Sebastian E. Winter; Jishnu Das; Joseph F. Pierre; Giorgio Trinchieri; Marlies Meisel
errShare
errSave
Phase I trial of ATR inhibitor elimusertib with FOLFIRI in advanced or metastatic gastrointestinal malignancies (ETCTN 10406)
err2025-01-22
err1
PREAI
errKrishnamurthy, Anuradha; Wang, Hong; Rhee, John C.; Davar, Diwakar; Moy, Ryan H.; Ratner, Lee; Christner, Susan M.; Holleran, Julianne L.; Deppas, Joshua; Sclafani, Carina; Schmitz, John C.; Gore, Steve; Chu, Edward; Bakkenist, Christopher J.; Beumer, Jan H.; Villaruz, Liza C.
errShare
errSave
Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV-GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors
err2024-11-17
err0
errOAAI
errDavar, Diwakar; Carneiro, Benedito A.; Dy, Grace K.; Sheth, Siddharth; Borad, Mitesh J.; Harrington, Kevin J.; Patel, Sandip P.; Galanis, Evanthia; Samson, Adel; Agrawal, Sonia; Chen, Zhongying; Fan, Chunling; Gong, Maozhen; Burton, Jenny; Tu, Eric; Durham, Nicholas; Laubscher, Kevin; Arnaldez, Fernanda; Zamarin, Dmitriy
errShare
errSave
Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy
err2024-10-22
err0
errOAAI
errHicks, William H.; Gattie, Lauren C.; Shami, Mohamad El; Traylor, Jeffrey I.; Davar, Diwakar; Najjar, Yana G.; Richardson, Timothy E.; Mcbrayer, Samuel K.; Abdullah, Kalil G.
errShare
errSave
Association of a blood T cell fitness gene signature with clinical benefit from ImmTAC bispecific T cell engagers
err2024-09-01
err0
PREAI
errSacco, J. J.; Carvajal, R. D.; Hamid, O.; Kirk, P. B.; Collins, L.; Butler, M. O.; Shoushtari, A. N.; Hassel, J. C.; Ikeguchi, A. P.; Hernandez-Aya, L.; Nathan, P.; Piulats Rodriguez, J. M.; Shaw, H.; Davar, D.; Han, C.; Middleton, M. R.; Thistlethwaite, F.; Peck, F.; Ranade, K.; Sato, T.
errShare
errSave
Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, in combination with pembrolizumab
err2024-08-13
err1
errOAAI
errCavalcante, Ludimila; Chandana, Sreenivasa; Lakhani, Nehal; Enstrom, Amanda; LeBlanc, Heidi; Schmalz, Joseph; Lengyel, Krisztina; Schneider, Frank; Thomas, Heather; Chisamore, Michael J.; Peng, Stanford L.; Naumovski, Allison; Davar, Diwakar
errShare
errSave
Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2)
err2024-08-03
err1
errOAAI
errDavar, Diwakar; Cavalcante, Ludimila; Lakhani, Nehal; Moser, Justin; Millward, Michael; Mckean, Meredith; Voskoboynik, Mark; Sanborn, Rachel E.; Grewal, Jaspreet S.; Narayan, Ajita; Patnaik, Amita; Gainor, Justin F.; Sznol, Mario; Enstrom, Amanda; Blanchfield, Lori; Leblanc, Heidi; Thomas, Heather; Chisamore, Michael J.; Peng, Stanford L.; Naumovski, Allison
errShare
errSave
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
err2024-04-18
err5
errOAAI
errLuke, Jason J.; Davar, Diwakar; Andtbacka, Robert H.; Bhardwaj, Nina; Brody, Joshua D.; Chesney, Jason; Coffin, Robert; de Baere, Thierry; de Gruijl, Tanja D.; Fury, Matthew; Goldmacher, Gregory; Harrington, Kevin J.; Kaufman, Howard; Kelly, Ciara M.; Khilnani, Anuradha D.; Liu, Ke; Loi, Sherene; Long, Georgina, V; Melero, Ignacio; Middleton, Mark; Neyns, Bart; Pinato, David J.; Sheth, Rahul A.; Solomon, Stephen B.; Szapary, Philippe; Marabelle, Aurelien
errShare
errSave
Initial results from an open-label phase 1b/2 study of RP1 oncolytic immunotherapy in solid organ transplant recipients with advanced cutaneous malignancies (ARTACUS)
err2024-04-05
err1
PREAI
errMigden, Michael R.; Chai-Ho, Wanxing; Daniels, Gregory A.; Medina, Theresa; Wise-Draper, Trisha M.; Kheterpal, Meenal; Tang, Jennifer C.; Ibrahim, Sherrif F.; Bolotin, Diana; Verschraegen, Claire; Zeitouni, Nathalie C.; Tsai, Katy K.; Donthireddy, Laxminarasimha; Bommareddy, Praveen K.; Hou, Jeannie W.; Hong, Walter; Davar, Diwakar
errShare
errSave
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0
err2023-10-18
err8
errOAAI
errPavlick, Anna C.; Ariyan, Charlotte E.; Buchbinder, Elizabeth, I; Davar, Diwakar; Gibney, Geoffrey T.; Hamid, Omid; Hieken, Tina J.; Izar, Benjamin; Johnson, Douglas B.; Kulkarni, Rajan P.; Luke, Jason J.; Mitchell, Tara C.; Mooradian, Meghan J.; Rubin, Krista M.; Salama, April K. S.; Shirai, Keisuke; Taube, Janis M.; Tawbi, Hussein A.; Tolley, J. Keith; Valdueza, Caressa; Weiss, Sarah A.; Wong, Michael K.; Sullivan, Ryan J.
errShare
errSave
Phase I/II dose escalation and dose expansion study of TransCon IL-2 β/γ alone or in combination with pembrolizumab: Determination of recommended phase II dose (RP2D) for monotherapy
err2023-10-01
err1
errOAAI
errStarodub, A. N.; Kim, S-B.; Davar, D.; Powderly, J.; Hill, A. G.; Yeku, O.; Gabrail, N.; Krapp, C.; Pihl, S.; Chen, M.; Slavsky, S.; Castro, D. Torrejon; Singel, S. M.; Kwatra, V.
errShare
errSave
Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes
err2023-06-22
err4
errOAAI
errKarapetyan, Lilit; AbuShukair, Hassan M.; Li, Aofei; Knight, Andrew; Al Bzour, Ayah Nedal; MacFawn, Ian P.; Thompson, Zachary J.; Chen, Ann; Yang, Xi; Dadey, Rebekah; Karunamurthy, Arivarasan; De Stefano, Danielle Vargas; Sander, Cindy; Kunning, Sheryl R.; Najjar, Yana G.; Davar, Diwakar; Luke, Jason J.; Gooding, William; Bruno, Tullia C.; Kirkwood, John M.; Storkus, Walter J.
errShare
errSave
Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study
err2023-06-16
err11
errOAAI
errAugustin, Ryan C.; Huang, Ziyu; Ding, Fei; Zhai, Shuyan; McArdle, Jennifer; Santisi, Anthony; Davis, Michael; Sander, Cindy; Davar, Diwakar; Kirkwood, John M.; Delgoffe, Greg M.; Warner, Allison Betof; Najjar, Yana G.
errShare
errSave
Phase 1 dose-escalation study of SGN-TGT monotherapy in patients with advanced malignancies
err2023-04-14
err1
PREAI
errCabanas, Elena Garralda; Fontana, Elisa; Oberoi, Honey Kumar; Uboha, Nataliya V.; Dumbrava, Ecaterina E.; Calvo, Emiliano; Curigliano, Giuseppe; Davar, Diwakar; Keenan, Bridget K.; Lam, Vincent K.; Manda, Sudhir; Mehta, Amitkuma; Minchom, Anna; Moskowitz, Alison; Paluri, Ravi; Ribrag, Vincent; Richards, Donald; Siu, Lillian; Swiecicki, Paul; Wise-Draper, Trisha; Zain, Jasmine; Forero-Torres, Andres; Xu, Ping; Ansell, Stephen
errShare
errSave